Ninebot Medical: Abnormal stock trading fluctuations Remind of multiple investment risks.

Jiu'an Medical announced that the company's stock had a cumulative deviation from the closing price on May 21, 22, and 25, 2026, exceeding 20%, indicating abnormal fluctuations. The company is currently operating normally, with no undisclosed information to be disclosed, and the controlling shareholder and ultimate controller did not buy or sell the company's stock during this period. The company reminds investors that the stock price is at a high level, with speculation and volatility risks; there are risks of losses in scientific and technological investment; the proportion of diabetes diagnosis and treatment care business is low, and income is uncertain; there are currently no plans for mergers and acquisitions; a proposed cash dividend of 16.5 yuan per 10 shares is planned for the fiscal year 2025, totaling 691 million yuan, but the plan is still pending implementation.